"A CLINICAL TRIAL ON POLYCYSTIC OVERIAN SYNDROME"

A STUDY ON CONCEPT OF SANTARPANANIMITTAJA VIKARA WSR TO EPIDEMIOLOGY AND TREATMENT OF PCOS

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/12/038533

Enrollment

Registered

2021-12-09

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: PCOS patients with age between 16-35 years suffering from any of the two features in the following â?? Patients having mid body obesity (BMI 26-40) Patient suffering from oligomenorrhea (Duration of flow less than 2 days, interval between 2 cycles exceeding more than 35 days). At least one ovary showing PCOD (diagnosed by USG) ESHRE/ASRM- Rotterdam revised criteria for PCOD, 2003

Exclusion criteria

Exclusion criteria: Pregnant women. Patients with BMI less than 26. Patients suffering from any systemic diseases. Patient having congenital and structural abnormalities of uterus and adnexa. Patients having physiological infrequent menstruation. Lactating mother. Drug induced amenorrhea/oligomenorrhea. HIV, VDRL, HBsAg positive. Patients suffering from pelvic pathology including fibroid uterus, cervical polyp etc. Woman taking OCPs HB level less than 7 gm% Other etiologies (CAH, thyroid dysfunction, hyperprolactinemia, Cushing syndrome etc.)

Design outcomes

Primary

Measure	Time frame
Achievement of regular menstrual cycleTimepoint: 60 DAYS	—

Secondary

Measure	Time frame
Improvement in quality of life. Effect on LH and FSHTimepoint: 60 DAYS	—

Countries

India

Contacts

Public ContactDR REKHA SAINI

National Institute of Ayurveda

bhatnagarshailza@gmail.com9982942244

Outcome results